Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia
Bubik, Rachel J. , Aasum, Monica I., Tamminga, Linda M., Koehler, Amber B. , Behnken, Amy L., Harden, J, Hampel, Paul J. , Call, Timothy G. , Bailen, Rachel J , Harden, Jen, Kenderian, Saad S. , Chaffee, Kari G. , Wang, Yucai , Muchtar, Eli , Kay, Neil E. , Rabe, Kari G. , Ding, Wei , Parikh, Sameer A.

Mayo Clinic

Journal of Oncology Pharmacy Practice | April 2, 2025 | Volume: 32 | Issue: 5 | Pages: 875-882

10.1177/10781552251323195 | PMID 40170466 Get It

Purpose Venetoclax-based treatment for chronic lymphocytic leukemia (CLL) can be a logistically burdensome regimen due to extensive required monitoring of tumor lysis syndrome (TLS). The purpose of this study was to evaluate the feasibility and safety of pharmacist and registered nurse (RN) driven management of venetoclax ramp-up in CLL. Methods This was a prospective, pilot program for patients receiving venetoclax-based therapy for CLL. Patients had nine weekly visits during the first three cycles of therapy, of which five visits were independently performed by a pharmacist or RN. Laboratory tests to evaluate TLS were ordered and monitored independently by the RN in collaboration with clinicians (physician, nurse practitioner, physician assistant). Results Thirty CLL patients, median age 67 years, 73% treated in the frontline setting, started venetoclax between May 2022 and January 2023. After the initial three weeks of obinutuzumab treatment, TLS risk prior to venetoclax initiation had improved to low (93%), medium (3%), and high (3%). There was zero incidence of laboratory or clinical TLS by Howard criteria during the venetoclax ramp-up for all patients. Pharmacist and RNs performed 139 independent visits and monitored 197 sets of TLS labs. Conclusion Use of independent pharmacist and RN visits for toxicity checks and TLS monitoring during weekly venetoclax dose ramp-up did not lead to increased incidence of TLS in patients with CLL. These visits increased both access and efficiency within the CLL clinic. This concept has the potential to be applied in other cancer care settings with a variety of treatment regimens.
Targeting IGF1 ‐Induced Cellular Senescence to Rejuvenate Hair Follicle Aging
Wang, Yang , Yang, Jian , Luo, Yue , Zhao, Zhiqiang , Yuan, Yawen, Li, Juan , Liu, Yang, Xu, Xiaoke , Lan, Yuankunyu, Zou, Juan , Li, Qintong , Pan, Yang , Yang, Yuanhan, Xiong, Muzhao, Li, Jinsong , Li, Weiyuxin , Cao, Yang , Zhu, Yi , Yang, Jian , Zhu, Yi , Xiao, Zhi‐Xiong Jim , Liu, Yang, Yi, Yong , Lan, Yuankunyu, Zou, Juan, Wang, Liang , Yang, Yuanhan, Wu, Min Cong , Zhang, Yujun

Mayo Clinic

Aging Cell | March 31, 2025 | Volume: 24 | Issue: 7 | Pages: No page available

10.1111/acel.70053 | PMID 40159808 Get It

ABSTRACT The insulin‐like growth factor‐1 (IGF‐1) signaling pathway is known as a potent aging modifier, disruption of which consistently associates with lifespan extension across diverse species. Despite this established association, the mechanisms by which IGF‐1 signaling modulates organ aging remain poorly understood. In this study, we assessed age‐related changes in IGF‐1 expression across multiple organs in mice and identified a more prominent increase in skin IGF‐1 levels with aging—a phenomenon also observed in human skin. To explore the consequences of elevated IGF‐1, we developed transgenic mice ectopically expressing human IGF‐1 in the epidermis, driven by the bovine keratin 5 promoter (IGF‐1 Tg). These mice exhibited premature aging of hair follicles, as evidenced by accelerated hair graying and loss. Single‐cell RNA sequencing analyses of dorsal skin highlighted an upsurge in cellular senescence markers and the senescence‐associated secretory phenotype (SASP) in hair follicle stem cells (HFSCs), alongside a decline in hair growth and HFSC exhaustion. Our findings indicate that excessive IGF‐1 triggers HFSC senescence, thereby disrupting hair follicle homeostasis. Remarkably, interventions in IGF‐1 signaling via downstream mechanisms—specifically blocking Ac‐p53 activation via SIRT1 overexpression or senolytic treatment for senescent cell clearance, or reducing IGF‐1 through dietary restriction—significantly reduced senescence markers, mitigated premature hair follicle aging phenotypes, and restored the stem cell pool. Our findings provide fundamental insights into the biological processes of hair aging and highlight the therapeutic promise of targeted interventions to rejuvenate aged HFSCs and promote hair follicle health.
Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older Adults
Hayes‐Larson, Eleanor , Andrews, Ryan M. , Kezios, Katrina , Bercu, Ariane, Rouanet, Anaïs , Helmer, Catherine , Crane, Paul K. , Klinedinst, Brandon S. , McEvoy, Linda K. , Weuve, Jennifer , Rajan, Kumar B. , Shaw, Crystal , Sims, Kendra D. , Therneau, Terry M. , Petersen, Ronald C., Bouteloup, Vincent , Gross, Alden L. , Albert, Marilyn, Morris, John C., Resnick, Susan M. , Turney, Indira C. , Vonk, Jet M. J. , Avila‐Rieger, Justina , Weigand, Alexandra J. , Chen, Ruijia , Wang, Jingxuan , Mayeda, Elizabeth Rose , Klinedinst, Brandon S , McEvoy, Linda K , Weuve, Jennifer , Mez, Jesse , Sims, Kendra D , Therneau, Terry , Albert, Marilyn S. , Masters, Colin L , Resnick, Susan M , Maruff, Paul , Manly, Jennifer J , Turney, Indira C , Vonk, Jet M J , Avila-Rieger, Justina , Weigand, Alexandra , Mayeda, Elizabeth Rose , Gibbons, Laura E. , Nichols, Emma , Rajan, Kumar Bharat , Hwang, Phillip H , Mez, Jesse , Farina, Mateo P. , Morris, John C. , Masters, Colin L. , Maruff, Paul , Manly, Jennifer J. , Proust‐Lima, Cécile

Mayo Clinic

Epidemiology | March 31, 2025 | Volume: 36 | Issue: 4 | Pages: 560-571

10.1097/ede.0000000000001859 | PMID 40164562 Get It

Background: Cognitive change is an important factor in understanding dementia. Estimating effects of exposures on cognitive change requires choosing an analytical timescale, typically time on study or current age. There is limited consensus regarding timescale choice in epidemiologic cognitive aging research. Methods: Using a coordinated analytic approach in 10 cohorts of older adults, we evaluated whether estimated effects of two exposures on memory change differed depending on timescale (time on study or current age). We modeled effects of apolipoprotein-E (APOE) ε4 genotype (a time-invariant exposure) and diabetes (a potentially time-varying/acquired exposure evaluated at baseline) using mixed-effects models with linear and nonlinear time specifications for both timescales. Results: Among APOE ε4 carriers, model-estimated memory scores at baseline (time on study timescale) or at each cohort’s median baseline age (current age timescale) were lower, and the average rate of decline was faster than among APOE ε4 noncarriers. Model-estimated memory scores at baseline or at median baseline age were generally similar across baseline diabetes status, with variability across cohorts in the diabetes-memory change association. In some cohorts, trends in diabetes-memory change associations differed in direction across timescales. Conclusions: Timescale was largely inconsequential for estimated effects of APOE genotype, but yielded differences in estimated diabetes effects, raising questions about the appropriate scale. The current age scale may be problematic because diabetes was measured heterogeneously in age across individuals, a common issue in aging cohorts. Our work demonstrates approaches to evaluate alternative timescales, including in multicohort analyses, and highlights potential implications for estimated exposure effects on cognitive change.
Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial
Desai, Milind Y. , Owens, Anjali , Saberi, Sara , Wang, Andrew , Wolski, Kathy, Cremer, Paul , Lakdawala, Neal K. , Tower‐Rader, Albree, Zenker, Mark, Geske, Jeffrey B. , Naidu, Srihari S. , Lampl, Kathy, Nissen, Steven E. , Investigators, for the VALOR-HCM, Wolski, Kathy , Cremer, Paul C , Tower-Rader, Albree , Sherrid, Mark , Geske, Jeffrey B , Fermin, David , Naidu, Srihari S , Nissen, Steven E , Saberi, Sara , Wang, Andrew , Zenker, Mark, Sherrid, Mark V. , Fermin, David , Investigators, for the VALOR-HCM

Mayo Clinic

Circulation: Genomic and Precision Medicine | March 31, 2025 | Volume: 18 | Issue: 3 | Pages: No page available

10.1161/circgen.125.005100 | PMID 40163785 Get It

Challenges of Ventilator Procurement and Distribution in the ICU During the COVID-19 Pandemic: A Scoping Review
Anjos, Gabriele A. dos, ZEC, SARA NAAS, Zambrano, Claudia Castillo , Rovati, Lucrezia , Dong, Yue , Nemet, Marko , Dos Anjos, Gabriele A, Zec, Sara N, Zambrano, Claudia C, Dong, Yue , Wang, David , Hieu, Truong Hong

Mayo Clinic

Critical Care Explorations | March 30, 2025 | Volume: 7 | Issue: 4 | Pages: e1248

10.1097/cce.0000000000001248 | PMID 40153548 Get It

OBJECTIVES: The goal of this scoping review was to review some of the challenges hospitals faced in dealing with the shortage of ventilators during the COVID-19 pandemic and the solutions they were able to implement or suggested. By highlighting these problems and solutions, we hope this review can catalyze further discussions about how to better prepare for future pandemics and medical supply shortages. DATA SOURCES: A comprehensive search strategy using identifying key words was applied to several different databases to procure relevant literature. STUDY SELECTION: Four thousand two hundred fifty-nine studies were found in the initial search. Inclusion and exclusion criteria were created and applied to screen studies. Included studies focused on the supply and distribution of ventilators during the COVID-19 pandemic. In the case where reviewers disagreed about whether a study should be included, a third reviewer acted as a tie-breaker. DATA EXTRACTION: Thirty-three studies were included for final data extraction. Two independent reviewers collected various data points from these studies, including the main challenges discussed by the authors, the level of ventilator shortage being addressed, whether ventilator sharing was discussed, and the limitations of the study. DATA SYNTHESIS: A third reviewer compared the collected data and decided on the results. CONCLUSIONS: Some of the common solutions for the ventilator shortage discussed included augmenting overall ventilator supply through increased production, transporting ventilators between hospitals, ventilator sharing, designing new ventilators, and repurposing other resources to help address shortages of supplies.
Interactions between genetic and epidemiological factors influencing mammographic density
Suger, Austin Hammermeister , Chen, Hongjie , Fan, Shaoqi , Bolla, Manjeet K. , Michailidou, Kyriaki , Wang, Qin , Fasching, Peter A. , Haeberle, Lothar, Aronson, Kristan J. , Eccles, Diana M, Evans, D. Gareth , Astley, Susan , Hall, Per, Pharoah, Paul D P, Antoniou, Antonis C, García‐Closas, Montserrat , González, Amy Berrington de , Easton, Douglas F. , Vachon, Celine M. , Lindström, Sara, Eccles, Diana , Fan, Shaoqi , Bolla, Manjeet K , Dennis, Joe , Michailidou, Kyriaki , Wang, Qin , Stone, Jennifer , Yadav, Siddhartha , Milne, Roger L , Norman, Aaron, Hall, Per N , Czene, Kamila , Pharoah, Paul D P , García-Closas, Montserrat , Easton, Doug , Eccles, Diana , Evans, D Gareth , Berrington de Gonzalez, Amy , Haas, Cameron B. , Scott, Christopher G. , Dunning, Alison M. , Stone, Jennifer , Gago-Domínguez, Manuela , Castelao, Jose E. , Murphy, Rachel A. , Couch, Fergus J. , Yadav, Siddhartha , Milne, Roger L. , Hopper, John L. , Norman, Aaron D. , Eliassen, A. Heather , Tapper, William , Czene, Kamila , Antoniou, Antonis C. , Gierach, Gretchen L. , Tamimi, Rulla M. , Vachon, Celine M. , Harrison, Tabitha A.

Mayo Clinic

American Journal of Epidemiology | March 30, 2025 | Volume: 195 | Issue: 5 | Pages: 1231-1241

10.1093/aje/kwaf067 | PMID 40153356 Get It

Abstract Studies have identified genetic and epidemiologic factors associated with mammographic density (MD) phenotypes. However, MD-associated genetic variants only account for a small proportion of the total estimated heritability. Interrogating interactions between genetic and epidemiologic factors could potentially identify additional MD-associated loci, expand our understanding of the genetic basis of MD phenotypes, and clarify how epidemiologic factors modulate relationships between genetic variants and MD. We conducted six separate genome-wide, gene–environment (GxE) interaction analyses, applying 2 degrees of freedom (df) and 1df interaction tests, for each of three MD phenotypes (percent density, dense area (DA), and nondense area (NDA)). The six epidemiologic factors considered were height, ever parous, parity, ever menopausal hormone therapy, ever breastfeeding, and months of breastfeeding. We included European ancestry participants from multiple studies within the Markers of Density consortium and the Breast Cancer Association Consortium (n = 4895-16 218 depending on specific analyses). We identified 11 loci with genome-wide significant (P < 5 × 10−8) interaction tests including two novel common genetic signals interacting with parity (8p21.2) and ever breastfeeding (19p13.2) for NDA. Our results suggest that epidemiologic risk factors might influence relationships between common genetic variants and MD phenotypes at particular genomic loci.
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
Ng, Wee Han , Wang, Yun , Trivedi, Hirsh D. , Ayoub, Walid S. , Parikh, Neehar D. , Sheng‐Kai, Kevin , Yang, Ju Dong , Parikh, Neehar D , Ma, Kevin Sheng-Kai , Ahn, Joseph , Yeo, Yee Hui , Kim, Hyun-Seok, Kuo, Alexander , Rich, Nicole E. , Abou‐Alfa, Ghassan K. , Singal, Amit G., Yang, Ju Dong

Mayo Clinic

Hepatology | March 30, 2025 | Volume: 83 | Issue: 2 | Pages: 249-260

10.1097/hep.0000000000001328 | PMID 40153442 Get It

Background and Aims: Immunotherapy has emerged as an effective treatment for advanced HCC. We aimed to investigate the real-world effectiveness of immunotherapy compared to lenvatinib in HCC. Approach and Results: From the TriNetX database, we used a target trial emulation framework and identified patients with HCC who received first-line treatment with immunotherapy (atezolizumab/bevacizumab or tremelimumab/durvalumab) or lenvatinib between or between August 2018 and December 2023. OS was compared using Kaplan-Meier analysis and Cox proportional hazards regression. After propensity score matching, 1203 patients were included in each group. Immunotherapy was associated with improved OS versus lenvatinib (median survival: 545 vs. 425 d; HR: 0.86, 95% CI: 0.76–0.97). Regarding treatment type, atezolizumab plus bevacizumab showed improved survival compared to lenvatinib (n=1070 in each group; HR: 0.87, 95% CI: 0.77–0.99), while the point estimate favored durvalumab plus tremelimumab versus lenvatinib (HR: 0.81, 95% CI: 0.59–1.12), though this difference was not statistically significant, likely due to small sample size. Regarding etiology, immunotherapy had improved OS compared to lenvatinib in viral hepatitis (n=510 in each group; HR: 0.74, 95% CI: 0.61–0.89) and alcohol-associated liver disease (n=190 in each group; HR: 0.65, 95% CI: 0.49–0.87), but not in metabolic dysfunction–associated steatotic liver diseases (n=156 in each group; HR: 0.96, 95% CI: 0.70–1.31). Conclusions: In this real-world analysis, immunotherapy was associated with improved OS compared to lenvatinib in advanced HCC, with consistent benefit across most subgroups. These findings support the use of immunotherapy as a first-line treatment for advanced HCC.
A novel mouse model of diverse tumors derived from epithelial cells
Wang, Lingxiang, Liu, Yang, Jahan‐mihan, Yasmin , He, Gordon, Hu, Jie , Bi, Yan , Ji, Baoan , Jahan-mihan, Yasmin, Wang, Yuxi, Ji, Baoan , Wang, Bin , Liu, Yang, He, Gordon, Wang, Di , Wang, Jiale

Mayo Clinic

Physiological Reports | March 30, 2025 | Volume: 13 | Issue: 7 | Pages: No page available

10.14814/phy2.70289 | PMID 40151103 Get It

AbstractA deeper understanding of pathophysiology, from the initiation of tumors of epithelial cells to the outcomes associated with it, is imperative to test potential interventions for these diseases. However, few models can accomplish this because of the complexity of origin cells and their transformation. We established an epithelial cell original tumor mouse model by conditional KrasG12D activation and tumor suppressor gene p53 deletion specifically in epithelial cells of the whole body using Cytokeratin 19 (CK19) promoter via Cre‐ERT mediation. Multiple tumors derived from epithelial cells developed in this novel model. This model can recapitulate the progress of intestinal, pancreatic, liver, lung, and subcutaneous tumors which derive from epithelial cells. This model is suitable for studying the pathophysiology of tumors derived from epithelial cells and may have the potential to test interventions.
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease
Alkhouri, Naim , Yip, Terry Cheuk‐Fung , Takawy, Marina , Adams, Leon A. , Jafri, Syed‐Mohammed , Zhong, Bihui , Chen, Vincent , Dunn, Nicholas , Nadeem, Rida, Wang, Zhengyi, Duseja, Ajay , Almahanna, Yousef , Omeish, Haya , Ye, Junzhao , Harrison, Stephen A. , Cristiu, Jessica , Robert, Sage, Bajunayd, Amani, Shao, Congxiang , Kubina, Matthew , Cheuk-Fung Yip, Terry , Castera, Laurent , Takawy, Marina , Verma, Nipun , Jafri, Syed-Mohammed , Chen, V L , Singal, Ashwani K , Díaz, Luis A , Dunn, Nicholas , Wong, Vincent Wai-Sun , Abdelmalek, Manal F. , Wang, Zhengyi , Duseja, Ajay , Almahanna, Yousef , Ye, Junzhao , Cristiu, Jessica , Arrese, Marco , Lai-Hung Wong, Grace , Kubina, Matthew , Dunn, Winston , Verma, Nipun , Arab, Juan Pablo , Zhong, Bihui , Dubourg, Julie , Singal, Ashwani K. , Díaz, Luis Antonio , Wong, Vincent Wai‐Sun , Omeish, Haya A. , Harrison, Stephen A. , Arrese, Marco , Wong, Grace Lai‐Hung , Dunn, Winston

Mayo Clinic

American Journal of Gastroenterology | March 30, 2025 | Volume: 121 | Issue: 2 | Pages: 362-374

10.14309/ajg.0000000000003432 | PMID 40146016 Get It

INTRODUCTION: The recent US Food and Drug Administration approval of resmetirom for treating metabolic dysfunction-associated steatohepatitis in patients necessitates patient selection for significant fibrosis or higher (≥F2). No existing vibration-controlled transient elastography (VCTE) algorithm targets ≥F2. METHODS: The mAchine Learning ADvanceD fibrosis and rIsk metabolic dysfunction-associated steatohepatitis Novel predictor (ALADDIN) study addressed this gap by introducing a machine-learning-based web calculator that estimates the likelihood of significant fibrosis using routine laboratory parameters with and without VCTE. Our study included a training set of 827 patients, a testing set of 504 patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease from 6 centers, and an external validation set of 1,299 patients from 9 centers. Five algorithms were compared using area under the curve (AUC) in the test set: ElasticNet, random forest, gradient boosting machines, XGBoost, and neural networks. The top 3 (random forest, gradient boosting machines, and XGBoost) formed an ensemble model. RESULTS: In the external validation set, the ALADDIN-F2-VCTE model, using routine laboratory parameters with VCTE (AUC 0.791, 95% confidence interval [CI]: 0.764–0.819), outperformed VCTE alone (0.745, 95% CI 0.717–0.772, P < 0.0001), FibroScan-aspartate aminotransferase (0.710, 0.679–0.748, P < 0.0001), and Agile-3 model (0.740, 0.710–0.770, P < 0.0001) regarding the AUC, decision curve analysis, and calibration. The ALADDIN-F2-Lab model, using routine laboratory parameters without VCTE, achieved an AUC of 0.706 (95% CI: 0.668–0.749) and outperformed Fibrosis-4, steatosis-associated fibrosis estimator, and LiverRisk scores. DISCUSSION: Along with the steatosis-associated fibrosis estimator model developed to target significant fibrosis or higher, ALADDIN-F2-VCTE (https://aihepatology.shinyapps.io/ALADDIN1) uniquely supports a refined noninvasive approach to patient selection for resmetirom without the need for liver biopsy. In addition, ALADDIN-F2-Lab (https://aihepatology.shinyapps.io/ALADDIN2) offers an effective alternative when VCTE is unavailable.
Neuronal ABCA7 deficiency aggravates mitochondrial dysfunction and neurodegeneration in Alzheimer's disease
Wang, Ni , Pan, Yining , Starling, Skylar C , Haskell, Devon H., Quintero, Astrid, Kawatani, Keiji , Inoue, Yasuteru , Ma, Xiaoye, Aikawa, Tomonori , Martens, Yuka A. , Kurti, Aishe, Parsons, Tammee M., Perkerson, Ralph B., Ren, Yingxue , DeTure, Michael , Bao, Hanmei , Kanekiyo, Takahisa , Quintero, Astrid C, Shue, Francis , Roy, Bhaskar, Raulin, Ana‐Caroline , Dickson, Dennis W. , Han, Xianlin , Bu, Guojun

Mayo Clinic

Alzheimer's & Dementia | March 29, 2025 | Volume: 21 | Issue: 3 | Pages: No page available

10.1002/alz.70112 | PMID 40145325 Get It

Abstract INTRODUCTION Loss‐of‐function variants of the ABCA7 gene are associated with an increased risk of Alzheimer's disease (AD). How neuronal ABCA7 contributes to AD pathogenesis is unknown. METHODS Using neuron‐specific Abca7 KO mice (n Abca7 −/− ) with or without 5×FAD amyloid model background and post mortem AD brains, we investigated AD‐related phenotypes through comprehensive approaches including transcriptomics and lipidomics. RESULTS Lipidomics analysis detected altered lipid profiles in the brains and synaptosomes of 5×FAD; n Abca7 −/− mice compared to controls. Transcriptomics profiling revealed that neuronal ABCA7 deficiency altered the expression of genes and pathways related to mitochondrial homeostasis and apoptosis, particularly in excitatory neurons. Consistently, synaptosomes isolated from 5×FAD; n Abca7 −/− mice showed diminished mitochondria respiration and reduced synaptic protein levels, which is further supported by results from human AD brains. DISCUSSION Our findings reveal that neuronal ABCA7 plays a critical role in mitochondrial homeostasis important for neuronal function and survival in the presence of AD pathology. Highlights Neuronal ABCA7 deficiency exacerbates Aβ pathology and neuronal damage in 5×FAD mice. Neuronal ABCA7 deficiency alters brain transcriptomes and lipidomes of 5×FAD mice. Neuronal ABCA7 deficiency disturbs mitochondria functions in synaptosomes from 5×FAD mice. Neuronal ABCA7 expression associates with genes and pathways related to mitochondrial homeostasis in AD brains.